Tom Goodman leads AzTE’s commercialization efforts in the life sciences. Working with a team of business development, patent, and marketing professionals, he manages the process of ASU technology translation from invention disclosure to final license agreement.
Previously Goodman was Chief Product Development Officer at the Cancer Prevention and Research Institute of Texas (CPRIT). There he oversaw CPRIT’s process for making grant awards to commercial entities. During his tenure, more than $100 million in such awards were approved.
Goodman has over 20 years’ experience in technology transfer, licensing, and business development in the life sciences. As Vice President of Diagnostics at Valeo Medical, he directed the development of the company’s immunoassay for endometriosis and oversaw their patent and licensing activities. Prior to Valeo, he was a Director at Research Corporation Technologies. There he led the selection and evaluation process for new venture investments and was responsible for out-licensing numerous university technologies. Goodman also worked in the diagnostics industry at Syva Company. He led the team that cloned and expressed a series of recombinant G6PDH enzymes to improve Syva’s EMIT® product line, and he managed the development of novel immunoassays for Type I diabetes, candidiasis, and homocysteine.
Goodman received his Ph.D. in Biochemistry from the University of Wisconsin, Madison. He did postdoctoral work in Germany with a fellowship from the Alexander von Humboldt Stiftung. He earned his M.B.A. from the Haas School of Business at the University of California, Berkeley. He has published 17 scientific papers and is an inventor on 11 issued U.S. patents.